The Contribution of “Individual Participant Data” Meta-Analyses of Psychotherapies for Depression to the Development of Personalized Treatments: A Systematic Review
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
While randomized trials typically lack sufficient statistical power to identify predictors and moderators of outcome, ”individual participant data” (IPD) meta-analyses, which combine primary data of multiple randomized trials, can increase the statistical power to identify predictors and moderators of outcome. We conducted a systematic review of IPD meta-analyses on psychological treatments of depression to provide an overview of predictors and moderators identified. We included 10 (eight pairwise and two network) IPD meta-analyses. Six meta-analyses showed that higher baseline depression severity was associated with better outcomes, and two found that older age was associated with better outcomes. Because power was high in most IPD meta-analyses, non-significant findings are also of interest because they indicate that these variables are probably not relevant as predictors and moderators. We did not find in any IPD meta-analysis that gender, education level, or relationship status were significant predictors or moderators. This review shows that IPD meta-analyses on psychological treatments can identify predictors and moderators of treatment effects and thereby contribute considerably to the development of personalized treatments of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636 · cited 1×
“The quality of the included meta-analyses was assessed with the AMSTAR-2 (“MeaSurement Tool to Assess systematic Reviews”), a critical appraisal tool for systematic reviews [10].”
MethodKaryotaki, E., Efthimiou, O., Miguel, C., Maas genannt Bermpohl, F., Furukawa, T. A., Cuijpers, P., Individual Patient Data Meta-Analyses for Depression (IPDMA-DE) Collaboration, Riper, H., Patel, V., Mira, A., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.4364 · Cited by 866
Self-citationKuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., Hayes, R., Huijbers, M., Ma, H., Schweizer, S., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0076 · Cited by 821
Subgroup analyses in randomized trials: risks of subgroup-specific analyses;
Brookes, S. T., Whitely, E., Egger, M., Smith, G. D., Mulheran, P. A., & Peters, T. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.009 · Cited by 775 · cited 1×
“The required sample size increases exponentially to a factor of more than 100 for more subtle interactions of <20% of the overall effect [7].”
BackgroundCuijpers, P., Noma, H., Karyotaki, E., Vinkers, C. H., Cipriani, A., & Furukawa, T. A. (2020) · World Psychiatry · doi:10.1002/wps.20701 · Cited by 540 · cited 2×
“…use, anxiety, medical condition, and level of education were not associated with outcome. a) Extensive definitions of the different types of therapies can be found in Cuijpers et al., 2020. b) Predictors defined as characteristics that indicate whether a patient benefits from a treatment or not.”
BackgroundSelf-citationTurner, J. A., Holtzman, S., & Mancl, L. (2007) · Pain · doi:10.1016/j.pain.2006.09.005 · Cited by 530
Cuijpers, P., Quero, S., Noma, H., Ciharova, M., Miguel, C., Karyotaki, E., Cipriani, A., Cristea, I. A., & Furukawa, T. A. (2021) · World Psychiatry · doi:10.1002/wps.20860 · Cited by 388
Self-citationBower, P., Kontopantelis, E., Sutton, A., Kendrick, T., Richards, D. A., Gilbody, S., Knowles, S., Cuijpers, P., Andersson, G., Christensen, H., et al. (2013) · BMJ · doi:10.1136/bmj.f540 · Cited by 341
Self-citationKaryotaki, E., Ebert, D. D., Donkin, L., Riper, H., Twisk, J., Burger, S., Rozental, A., Lange, A., Williams, A. D., Zarski, A. C., et al. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.06.007 · Cited by 303 · cited 3×
“One IPD meta-analysis focused on specific predictors of outcome of guided iCBT compared to control groups [15].”
BackgroundMethodSelf-citationThe effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review
Cuijpers, P., Karyotaki, E., de Wit, L., & Ebert, D. D. (2020) · Psychotherapy Research · doi:10.1080/10503307.2019.1649732 · Cited by 276 · cited 1×
“It is suspected that variables such as comorbid personality problems, comorbid substance use problems, childhood adversities, traumas, the duration of depressive symptoms, the number of previous episodes and available coping resources are important candidates for significant predictors and moderators [28,29].”
BackgroundSelf-citation
Cited by
A systematic review of digital and face-to-face cognitive behavioral therapy for depression
Kambeitz-Ilankovic, L., Rzayeva, U., Völkel, L., Wenzel, J., Weiske, J., Jessen, F., Reininghaus, U., Uhlhaas, P. J., Alvarez-Jimenez, M., & Kambeitz, J. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00677-8 · Cited by 103
Purgato, M., Prina, E., Ceccarelli, C., Cadorin, C., Abdulmalik, J. O., Amaddeo, F., Arcari, L., Churchill, R., Jordans, M. J., Lund, C., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014722.pub2 · Cited by 27
Self-citation(2024) · PubMed Central · doi:10.36131/cnfioritieditore20240302 · Cited by 5
Metadata
- Authors
- Cuijpers, P., Ciharova, M., Quero, S., Miguel, C., Driessen, E., Harrer, M., Purgato, M., Ebert, D., & Karyotaki, E.
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2022-01-11
- Volume
- 12
- Issue
- 1
- Pages
- 93
- ISSN
- 2075-4426 (ISSN-L)
- OpenAlex
- W4206844000
- Cited by
- 55
- References
- 21
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.